Trends and three-year outcomes of hepatitis C virus-viremic donor heart transplant for hepatitis C virus-seronegative recipients.
JTCVS Open
; 12: 269-279, 2022 Dec.
Article
en En
| MEDLINE
| ID: mdl-36590744
D+, HCV-viremic donor; DAAs, direct-acting antivirals; DCD, donation after circulatory death; D, HCV-seronegative donor; ECMO, extracorporeal membranous oxygenation; HCV, hepatitis C virus; HT, heart transplant; IABP, intra-aortic balloon pump; IQR, interquartile range; LVAD, left ventricular assist device; MCS, mechanical circulatory support; R, HCV-seronegative recipient; SRTR, Scientific Registry of Transplant Recipients; aHR, adjusted hazard ratio; aOR, adjusted odds ratio; donor pool; heart transplant; hepatitis C; outcomes
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
JTCVS Open
Año:
2022
Tipo del documento:
Article
País de afiliación:
Moldova
Pais de publicación:
Países Bajos